scholarly journals Measures of chronic heart failure as the markers of cognitive dysfunction in patients with coronary heart disease complicated by circulatory failure

Cor et Vasa ◽  
2021 ◽  
Vol 63 (1) ◽  
pp. 20-24
Author(s):  
Natalya S. Akimova ◽  
Oksana V. Bugaeva ◽  
Larisa E. Konshina ◽  
Yury G. Shvarts
Keyword(s):  
Heart Failure ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chronic Heart Failure ◽  
Cognitive Dysfunction ◽  
Circulatory Failure

The value of the parameters of the severity of chronic heart failure in the assessment of cognitive dysfunction in patients with coronary heart disease

Therapy ◽  
2021 ◽  
Vol 3_2021 ◽  
pp. 20-27
Author(s):  
Akimova N.S. Akimova ◽  
Bugaeva O.V. Bugaeva ◽  
Sokolov I.M. Sokolov ◽  
Schwartz E.Yu. Schwartz ◽  
Kiselev A.R. Kiselev ◽  
...  
Keyword(s):  
Heart Failure ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chronic Heart Failure ◽  
Cognitive Dysfunction

scholarly journals PHARMACOLOGICAL TREATMENT OF OSTEOPOROSIS IN PATIENTS WITH CORONARY HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE

2019 ◽  
Vol 12 (1) ◽  
pp. 443
Author(s):  
Mariya Marushchak ◽  
Inna Krynytska
Keyword(s):  
Heart Failure ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Lumbar Spine ◽  
Chronic Heart Failure ◽  
Vitamin D3 ◽  
Femoral Bone ◽  
Metabolic Disturbances ◽  
Mineral Density ◽  
Multisystem Disorder

Objective: Chronic heart failure (CHF) is a chronic multisystem disorder associated with a myriad of metabolic disturbances. Moreover, CHF may adversely affect bone metabolism and induce a severe bone loss, increasing susceptibility to fractures and osteoporosis. This study investigates the effect of combined calcium with Vitamin D3 supplement called “calcemin advance” and calcitonin in the prophylaxis and treatment of osteopenia and osteoporosis in patients with coronary heart disease (CHD) complicated by CHF with the establishment of their influence on the bone mineral density (BMD).Methods: A total of 59 patients with CHD complicated by CHF. Interventions: The physical examination findings, dual-energy X-ray absorptiometry findings, and treatment results were assessed.Results: The results of the calcemin advance usage in patients with osteopenic changes showed a positive dynamics of the studied parameters, both in the lumbar spine and in the femoral bone. In patients with osteoporosis, the usage of osteoprotective therapy (calcemin advance+miacalcic) contributed to the increasing of BMD in the lumbar spine and in the femoral bone versus patients who received only combined calcium with Vitamin D3 supplement.Conclusions: Our results suggest that bone density screening could be recommended in patients with prevalent CHF. Moreover, the results of our investigation substantiate the necessity and effectiveness of osteoprotective therapy in patients with CHF with osteoporosis by calcitonin (Miacalcic), in combination with combined calcium and Vitamin D3 supplement (calcemin advance), and by only calcemin advance - in patients with CHF and osteopenia.

scholarly journals GENE polymorphism of the renin angiotensin system in patients with arterial hypertension and coronary heart disease complicated by chronic heart failure

2005 ◽  
Vol 11 (4) ◽  
pp. 235-238
Author(s):  
N. P. Dorofeev ◽  
A. A. Kastanayan ◽  
S. V. Shlyk ◽  
V. V. Dorofeikov ◽  
A. A. Barbina ◽  
...  
Keyword(s):  
Heart Failure ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chronic Heart Failure ◽  
Gene Polymorphism ◽  
Arterial Hypertension ◽  
Renin Angiotensin System ◽  
Type I ◽  
Hypertensive Disease ◽  
Angiotensin System

The purpose of the Study was to search for an association of the gene polymorphism of angiotensin-converting enzyme (ACE), angiotensinogen (ATG) and type I receptors of angiotensin II with the risk for chronic heart failure in patients with coronary heart disease (CHD) and arterial hypertension (AH). A hundred persons, including 80 patients with CHD, 10 patients with hypertensive disease, and 10 healthy Individuals were examined. There was no association of the ID gene polymorphism of ACE, MT gene polymorphism of ATG, and the AC gene polymorphism of ATR1 with the risk for heart failure in patients with CHD and AH.

Sign in / Sign up

Export Citation Format

Share Document